Back to Search
Start Over
A cisplatin-gemcitabine-vinorelbine (PVG) first-line treatment in IIIB-IV non small cell lung cancer (NSCLC)
- Source :
- Journal of Clinical Oncology. 22:7123-7123
- Publication Year :
- 2004
- Publisher :
- American Society of Clinical Oncology (ASCO), 2004.
-
Abstract
- 7123 Background: The purpose of this monocenter phase II trial was to evaluate activity and toxicity profile of PGV schedule as first-line treatment in patients (pts) with NSCLC stage IIIB-IV. Meth...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
Meth
medicine.disease
Vinorelbine
respiratory tract diseases
First line treatment
chemistry.chemical_compound
chemistry
Internal medicine
Medicine
In patient
Cisplatin/gemcitabine
Stage (cooking)
business
Toxicity profile
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........50deead2b2efa7bd679ee4a5f7233315
- Full Text :
- https://doi.org/10.1200/jco.2004.22.90140.7123